Blood test aims to catch Cancer's return before scans can
NCT ID NCT07382505
Summary
This study is testing a blood test to see if it can find tiny traces of cancer left behind after treatment for uterine or cervical cancer. Researchers will follow 600 patients, taking blood samples regularly to check if the test can spot a recurrence earlier than standard scans or exams. The goal is to learn if this 'liquid biopsy' can help doctors monitor patients more closely and personalize follow-up care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
Seoul, Seoul, 05505, South Korea
Conditions
Explore the condition pages connected to this study.